Serum immunoglobulins G, A, M, D and E concentrations in lymphomas

|September 1, 1979

Summary

Serum immunoglobulin levels, including IgG and IgE, were elevated in patients with untreated Hodgkin

Area of Science:

Background:

Hodgkin's disease (HD) and non-Hodgkin lymphomas (NHL) are distinct hematologic malignancies.
Immunoglobulin levels can be altered in lymphoproliferative disorders.
Understanding these alterations is crucial for diagnosis and prognosis.

Purpose of the Study:

To investigate serum immunoglobulin profiles in untreated Hodgkin's disease.
To compare immunoglobulin levels across different HD histological subtypes and disease stages.
To examine the impact of radiotherapy and chemotherapy on immunoglobulin levels in HD.
To analyze immunoglobulin levels in non-Hodgkin lymphomas based on histology.

Main Methods:

Measurement of serum immunoglobulin (IgG, IgA, IgM, IgD, IgE) levels.
Patient cohorts included 105 untreated Hodgkin's disease patients and 80 non-HD lymphoma patients.
Analysis correlated immunoglobulin levels with HD histological type, disease stage, and treatment status.
Paired serum samples were analyzed before and after treatment (radiotherapy/chemotherapy).

Main Results:

Significant increases in IgG and IgE were observed in the overall HD group.
Specific Ig increases (IgG, IgA, IgE) varied by HD histological type (nodular sclerosis, mixed-cellularity, lymphocyte-predominant).
Disease stage influenced Ig levels: IgG, IgA, and IgE increased in Stages II/III, while IgM (males) and IgD decreased in Stage IV.
Radiotherapy led to decreases in IgM and IgD; chemotherapy reduced all Ig classes except IgD.
Non-HD lymphomas showed decreased IgM (females), IgG, and IgA; specific decreases were noted in well-differentiated lymphocytic lymphomas (all Ig classes) and poorly differentiated lymphocytic lymphomas (IgA).

Conclusions:

Serum immunoglobulin alterations are characteristic of Hodgkin's disease, varying by histology and stage.
Treatment modalities significantly impact immunoglobulin levels in HD patients.
Distinct immunoglobulin patterns are observed in non-Hodgkin lymphomas, correlating with histological subtypes.

Related Experiment Videos